Company Name: |
BOC Sciences
|
Tel: |
|
Email: |
info@bocsci.com |
Products Intro: |
Product Name:GW841819X CAS:146135-18-4 Purity:98% Remarks:GW841819X, a benzodiazepin derivative, has been found to be a BET bromodomains inhibitor that could be probably significant in the study of myeloma and leukemia at some extent.
|
Company Name: |
Nantong QuanYi Biotechnology Co., Ltd
|
Tel: |
0513-66337626 18051384581 |
Email: |
sales@chemhifuture.com |
Products Intro: |
Product Name:GW 841819X CAS:146135-18-4 Purity:98%+ HPLC Package:10mg,500mg,1g,2g,5g,10g,more
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:GW-841819X CAS:146135-18-4 Package:50mg/RMB 13800;25mg/RMB 10600;100mg/RMB 17500
|
CarbaMic acid, (1-Methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)-, phenylMethyl ester (9CI) manufacturers
- GW-841819X
-
- $1980.00 / 50mg
-
2024-10-28
- CAS:146135-18-4
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| CarbaMic acid, (1-Methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)-, phenylMethyl ester (9CI) Basic information |
Product Name: | CarbaMic acid, (1-Methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)-, phenylMethyl ester (9CI) | Synonyms: | CarbaMic acid, (1-Methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)-, phenylMethyl ester (9CI);TUWDLUFFAHHNEF-UHFFFAOYSA-N;Carbamic acid, N-(1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)-, phenylmethyl ester | CAS: | 146135-18-4 | MF: | C25H21N5O2 | MW: | 423.46654 | EINECS: | | Product Categories: | | Mol File: | 146135-18-4.mol | |
| CarbaMic acid, (1-Methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)-, phenylMethyl ester (9CI) Chemical Properties |
| CarbaMic acid, (1-Methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)-, phenylMethyl ester (9CI) Usage And Synthesis |
Description | GW841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomains. GW841819X displayed activity in vivo against NUT-midline carcinoma, multiple myeloma, mixed-lineage leukemia, and acute myeloid leukemia. Bromodomain and extra-terminal (BET) proteins belong to a class of proteins collectively called epigenetic "readers". BET bromodomains have emerged as promising drug targets for treatment of cancers, inflammatory diseases, and other medical conditions. |
| CarbaMic acid, (1-Methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl)-, phenylMethyl ester (9CI) Preparation Products And Raw materials |
|